1. Ahlund, L., Lundgren, Y., Sjoberg, B. and Weiss, L. (1977). Vascular reactivity to 5-hydroxytryptamine (5-HT) in hindquarter vascular beds, aortic strips and portal veins from spontaneously hypertensive and normotensive rats. Acta Physiol. Scand., 101, 489–492
2. Ashton, J. H., Benedict, C. R., Fitzgerald, C., Raheja, S., Taylor, A., Campbell, W. B., Buja, L. M. and Willerson, J. T. (1986). Serotonin as a mediator of cyclic flow variations in stenosed canine coronary arteries. Circulation, 73, 572–578
3. Awouters, F., Leysen, J. E., De Clerck, F. and Van Nueten, J. M. (1982). General pharmacological profile of ketanserin (R 41 468), a selective 5-HT2 receptor antagonist. In De Clerck, F. and Vanhoutte, P. M. (Eds), 5-Hydroxytryptamine in Peripheral Reactions, Raven Press, New York, pp. 193–197
4. Awouters, F., Niemegeers, C. J. E. and Janssen, P. A. J.(1985). A pharmacological analysis of the rat mast cell 5-HT gastric ulcer test and the effects of ketanserin. Drug Devel Res., 5, 303–312
5. Cocks, T. M. and Angus, J. A. (1983). Endothelium dependent relaxation of coronary arteries by noradrenaline and serotonin. Nature, 305, 627–630